Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
26.44
-1.30 (-4.69%)
At close: Oct 7, 2025, 4:00 PM EDT
26.96
+0.52 (1.97%)
After-hours: Oct 7, 2025, 6:48 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.22 billion as of October 7, 2025. Its market cap has increased by 64.61% in one year.
Market Cap
1.22B
Enterprise Value
970.65M
1-Year Change
64.61%
Ranking
Category
Stock Price
$26.44
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.22B, an increase of 102.73%. That is a compound annual growth rate of 70.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 1.28B | 97.14% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |